AB (Wuhan) Biotech Co. Ltd. is an emerging biotechnology research and product development company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value.

Our company specializes in developing innovative rapid diagnostic tests tests/assays for clients. Our products range from contract development to providing reagents necessary, colloidal gold technologies, and various rapid diagnostic devices for human and animal diseases, such as cardiovascular disease and zoonoses.

Our company is headquartered with offices, a Research and Development Center and a state of the art production facility in Wuhan, China. 

Management Team

A successful biotech company cannot thrive without a skilled research team capable of systematically developing products that address pressing healthcare needs. But, research expertise and commitment are not the sole basis for success. Financial and marketing counterparts, who excel at delivering a healthy bottom line, are integral to a company’s performance.

AB (Wuhan) Biotech has established a highly experienced management team with proven ability to balance the company’s significant R&D requirements with the need to return value to stockholders. The stability in our corporate officer ranks is a testament to our pride in AB (Wuhan) Biotech’s achievements to date and confidence in our long-term prospects. This kind of consistency and tenure provides significant benefits to our customers, shareholders and, more broadly, to the healthcare community.